The U.S. government is easing some rules on medical marijuana, reclassifying it from a Schedule 1 to a Schedule 3 drug, a move that aligns federal guidance with many state laws, even as marijuana ...

Louisiana will no longer be part of a lawsuit other states have filed to stop the Trump administration reclassification of ...

The DOJ reclassified medical marijuana from Schedule I to Schedule III, opening tax and research benefits. But recreational ...

For years, marijuana has been classified as a Schedule I drug under the federal Controlled Substance Act. Heroin, LSD, peyote, and quaaludes are other drugs that fall under the Schedule I ...

Medical marijuana licensees in Massachusetts can expect a range of potential changes following the Trump administration’s rescheduling of cannabis as a less dangerous class of drug Thursday, the ...

A renewed federal push to relax restrictions on marijuana likely will mean bigger profits for cannabis companies and more research into the effects of the plant, industry participants say. It may ...

For more than 50 years, marijuana has been classified as a Schedule I drug, alongside drugs considered to have no accepted medical use, thanks to then-President Richard Nixon’s so-called War on Drugs.

The complaint targets companies in 13 states and is brought by consumers who claim the products were deceptively marketed.

A federal class-action lawsuit is drawing comparisons between the cannabis industry and Big Tobacco.

Colorado’s cannabis dispensaries could get a long-awaited tax break and easier access to traditional banking services expedited by President Donald Trump’s executive order last month. Shop owners say ...

Oklahoma could soon see the impact of the federal government’s reclassification of medical marijuana. It was in the same class as heroin, but is now considered a less dangerous drug. Oklahoma could ...